Stephanie Larson @stephlarson3

Joined October 2014

Tweets

29
Followers

20
Following

302
Likes

120

Siteman Cancer Center @SitemanCenter

3 years ago

Congrats to Julie Hinchman and Kelly Terrell, the first recipients of the Peter Westervelt, MD, PhD, Nursing Education Fund Scholarship Award! This honor recognizes outstanding oncology nurses at Siteman by providing resources and support for continued education.

0 2 6 457 0

Download Image

Richmond Spiders Football @Spiders_FB

3 years ago

The kick is GOOD✅ @jakelarson42 hits a 44-yarder to extend Richmond's lead! 🕷️ 30 ⛰🐦 6 Qtr. 4 | 3:41 | #OneRichmond Scoring Drive Powered By @SeredniTireAuto

0 2 17 0 0

Download Gif

marquette cheer @marquettecheer

4 years ago

RIDE MUSTANGS RIDE!!! 💙💚

marquette cheer @marquettecheer

4 years ago

RIDE MUSTANGS RIDE!!! 💙💚 https://t.co/4iY4vxJaCP

0 1 3 0 0

Download Video

0 1 4 0 0

Download Image

Siteman Cancer Center @SitemanCenter

4 years ago

Siteman Deputy Director Dr. John DiPersio, MD, PhD, discusses the @WUSTLmed research being presented at #ASH21.

0 2 10 0 0

Download Video

Siteman Cancer Center @SitemanCenter

4 years ago

Join us live on Facebook this Tuesday, December 7, at 10 a.m, for a Cellular & CAR T-cell Therapies Q&A with @WUSTLmed experts Armin Ghobadi, MD, and Amanda Cashen, MD. Learn about these therapies and ask our experts questions throughout the event: ow.ly/XfK350H1pvv

0 1 4 0 0

Download Image

ASTCT @ASTCT

4 years ago

Now on Nucleus: "Bispecific T-cell engagers (BiTEs) and antibody-drug conjugates (ADCs) 'appear to have tolerable safety and reasonable efficacy profiles' in the treatment of relapsed or refractory multiple myeloma" nucleus.astct.org/Patient-Care/b…

0 1 2 0 0

Download Image

Siteman Cancer Center @SitemanCenter

5 years ago

The @acs_missouri #HopeLodgeSTL has been an incredible resource for so many Siteman patients. We're honored to host not one but two of the #42Doors of Hope on the grounds of Siteman's main campus (Door 22) and north county (Door 32) locations. Learn more: 42doorsofhope.org

0 2 5 0 0

Download Image

Siteman Cancer Center @SitemanCenter

6 years ago

Transitional Care Management, including the use of an upgraded EMR, has lowered 30-, 14- and 7-day readmission rates for BMT patients. See @TerrellK711's poster on retrospective outcome data: 6:15-7:45 pm, Palms & Cypress Foyers. ow.ly/Ugvb50ysCnM #TCTM20

0 1 3 0 0

Siteman Cancer Center @SitemanCenter

6 years ago

Ramzi Abboud, MD, (@ramziabb) will discuss data that’s the first to show that mild (grade 1-2) CRS is associated with a lower rate of relapse without affecting TRM, thereby improving OS, today at #TCTM20: 5 pm, Palms: Royal. Abstract: ow.ly/Y5ab50ysyJr

0 1 0 0 0

Siteman Cancer Center @SitemanCenter

6 years ago

CD34+ cell mobilization w/plerixafor + MGTA-145 is immediate and superior to plerixafor alone, according to a phase 1 clinical study led by our deputy director, John DiPersio, MD, PhD. He presents findings today at #TCTM20: 4:45 pm, Palms: Royal. Abstract: ow.ly/oAsT50ytgLB

0 1 2 0 0

Stephanie Larson @stephlarson3

6 years ago

Love seeing our leaders at this national conference!

Siteman Cancer Center @SitemanCenter

6 years ago

Love seeing our leaders at this national conference!

0 1 5 0 0

Download Video

0 0 1 0 0

Siteman Cancer Center @SitemanCenter

6 years ago

Want to optimize your EMR system for CAR T-cell therapy? Andrea Price, NP, (@andiprice82) and Dylan Essner discuss the opportunities and pitfalls, at #TCTM20: 2:10 pm today in Palms: Canary 1-2. More info: ow.ly/TwRf50yqRjI

1 4 8 0 0

Download Video

Stephanie Larson @stephlarson3

6 years ago

Looking forward to highlighting our Cellular Therapy Program tomorrow! We have lots of brilliant team members presenting at the conference #TCTM20 !

Siteman Cancer Center @SitemanCenter

6 years ago

Looking forward to highlighting our Cellular Therapy Program tomorrow! We have lots of brilliant team members presenting at the conference #TCTM20 !

0 1 4 0 0

0 0 1 0 0

Siteman Cancer Center @SitemanCenter

6 years ago

.@WUSTLmed has received a $5M grant from the Edward P. Evans Foundation to establish a new center focused on researching & improving treatments for myelodysplastic syndromes, or #MDS, a rare set of blood disorders. The new center will be led by Siteman's Matthew Walter, MD.